Chemotherapy Compounding Payment Scheme

From 1 September 2016, information needed to claim infusible chemotherapy items from the Pharmaceutical Benefits Scheme (PBS) is changing.

Approved suppliers such as pharmacists, medical practitioners and hospital authorities will be asked to provide new information when claiming infusible chemotherapy items through the PBS.

New data fields within the PBS online claiming system for infusible chemotherapy claims include:

  • compounder ID - to indicate the compounder of the infusion, and
  • infusion ID - automatically generated by PBS dispensing software for each infusion

Compounders will provide approved suppliers with the compounder ID for the relevant compounding sites.

These changes provide:

  • data on chemotherapy compounding for payments to TGA-licensed compounders on the basis of PBS transaction data, and
  • a better understanding of the scope of chemotherapy compounding in Australia

Including compounder and infusion IDs in infusible chemotherapy claims is optional but will be mandatory from April 2017.

Next steps

Read more about:

Subscribe to news for health professionals and get regular updates directly to your inbox.

Page last updated: 30 September 2016

This information was printed Saturday 10 December 2016 from humanservices.gov.au/health-professionals/news/chemotherapy-compounding-payment-scheme It may not include all of the relevant information on this topic. Please consider any relevant site notices at humanservices.gov.au/siteinformation when using this material.